HEADER TRANSFERASE 01-JUN-16 5L72 TITLE PI3 KINASE DELTA IN COMPLEX WITH N-[6-(5-METHANESULFONAMIDO-6- TITLE 2 METHOXYPYRIDIN-3-YL)-1,3-DIHYDRO-2-BENZOFURAN-4-YL]-2-(MORPHOLIN-4- TITLE 3 YL)ACETAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE CATALYTIC COMPND 3 SUBUNIT DELTA ISOFORM; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: PI3-KINASE SUBUNIT DELTA,PI3K-DELTA,PI3KDELTA,PTDINS-3- COMPND 6 KINASE SUBUNIT DELTA,PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE 3-KINASE COMPND 7 110 KDA CATALYTIC SUBUNIT DELTA,PTDINS-3-KINASE SUBUNIT P110-DELTA, COMPND 8 P110DELTA; COMPND 9 EC: 2.7.1.137,2.7.1.153; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: PIK3CD; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS PI3 KINASE DELTA, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR P.ROWLAND REVDAT 3 29-SEP-21 5L72 1 COMPND DBREF SEQADV REVDAT 2 24-AUG-16 5L72 1 JRNL REVDAT 1 27-JUL-16 5L72 0 JRNL AUTH A.AMOUR,N.BARTON,A.W.COOPER,G.INGLIS,C.JAMIESON, JRNL AUTH 2 C.N.LUSCOMBE,J.MORRELL,S.PEACE,D.PEREZ,P.ROWLAND,C.TAME, JRNL AUTH 3 S.UDDIN,G.VITULLI,N.WELLAWAY JRNL TITL EVOLUTION OF A NOVEL, ORALLY BIOAVAILABLE SERIES OF PI3K JRNL TITL 2 DELTA INHIBITORS FROM AN INHALED LEAD FOR THE TREATMENT OF JRNL TITL 3 RESPIRATORY DISEASE. JRNL REF J.MED.CHEM. V. 59 7239 2016 JRNL REFN ISSN 0022-2623 JRNL PMID 27429068 JRNL DOI 10.1021/ACS.JMEDCHEM.6B00799 REMARK 2 REMARK 2 RESOLUTION. 3.06 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.06 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 112.92 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 3 NUMBER OF REFLECTIONS : 18943 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.178 REMARK 3 R VALUE (WORKING SET) : 0.172 REMARK 3 FREE R VALUE : 0.277 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 967 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 3.06 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.23 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.79 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2834 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1904 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2688 REMARK 3 BIN R VALUE (WORKING SET) : 0.1819 REMARK 3 BIN FREE R VALUE : 0.3518 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.15 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 146 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6925 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 32 REMARK 3 SOLVENT ATOMS : 268 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 80.76 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 57.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 8.84920 REMARK 3 B22 (A**2) : -5.43680 REMARK 3 B33 (A**2) : -3.41230 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 7.13510 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.326 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.522 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.903 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.799 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 7110 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 9599 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2543 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 177 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 1029 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 7110 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 881 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 8451 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.13 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.54 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 21.72 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -20.1093 -14.7007 28.8532 REMARK 3 T TENSOR REMARK 3 T11: -0.1377 T22: -0.2658 REMARK 3 T33: -0.1831 T12: 0.0513 REMARK 3 T13: 0.0576 T23: -0.0506 REMARK 3 L TENSOR REMARK 3 L11: 1.1501 L22: 0.7842 REMARK 3 L33: 1.6138 L12: -0.1694 REMARK 3 L13: -0.1653 L23: 0.2108 REMARK 3 S TENSOR REMARK 3 S11: -0.0121 S12: 0.0876 S13: 0.0554 REMARK 3 S21: 0.0374 S22: -0.0887 S23: 0.0145 REMARK 3 S31: 0.0211 S32: -0.3242 S33: 0.1007 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5L72 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 01-JUN-16. REMARK 100 THE DEPOSITION ID IS D_1200000232. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-APR-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9763 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 65937 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.060 REMARK 200 RESOLUTION RANGE LOW (A) : 113.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.13900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.06 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.56300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.38 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.38 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: VAPOUR DIFFUSION USING MORPHEUS SCREEN REMARK 280 WITH CRYSTAL SEEDING, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 70.70000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.18000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 70.70000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 32.18000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 38610 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 105 REMARK 465 GLY A 106 REMARK 465 ASP A 107 REMARK 465 TRP A 178 REMARK 465 ARG A 179 REMARK 465 ALA A 180 REMARK 465 GLY A 181 REMARK 465 LEU A 182 REMARK 465 LEU A 183 REMARK 465 ARG A 184 REMARK 465 VAL A 185 REMARK 465 SER A 186 REMARK 465 PRO A 292 REMARK 465 ALA A 293 REMARK 465 PRO A 294 REMARK 465 GLN A 295 REMARK 465 VAL A 296 REMARK 465 GLN A 297 REMARK 465 LYS A 298 REMARK 465 PRO A 299 REMARK 465 ARG A 300 REMARK 465 ALA A 301 REMARK 465 LYS A 302 REMARK 465 PRO A 303 REMARK 465 PRO A 304 REMARK 465 PRO A 305 REMARK 465 ILE A 306 REMARK 465 PRO A 307 REMARK 465 ALA A 308 REMARK 465 LYS A 309 REMARK 465 LYS A 310 REMARK 465 PRO A 311 REMARK 465 SER A 312 REMARK 465 SER A 313 REMARK 465 VAL A 314 REMARK 465 GLU A 399 REMARK 465 LYS A 400 REMARK 465 ALA A 401 REMARK 465 LYS A 402 REMARK 465 LYS A 403 REMARK 465 ALA A 404 REMARK 465 ARG A 405 REMARK 465 SER A 406 REMARK 465 THR A 407 REMARK 465 LYS A 408 REMARK 465 LYS A 409 REMARK 465 LYS A 410 REMARK 465 SER A 411 REMARK 465 LYS A 412 REMARK 465 LYS A 413 REMARK 465 ALA A 414 REMARK 465 PRO A 446 REMARK 465 ASP A 447 REMARK 465 GLU A 448 REMARK 465 LYS A 449 REMARK 465 GLY A 450 REMARK 465 GLU A 451 REMARK 465 ARG A 518 REMARK 465 GLY A 519 REMARK 465 SER A 520 REMARK 465 GLY A 521 REMARK 465 PHE A 919 REMARK 465 LYS A 920 REMARK 465 THR A 921 REMARK 465 LYS A 922 REMARK 465 PHE A 923 REMARK 465 GLY A 924 REMARK 465 ILE A 925 REMARK 465 ASN A 926 REMARK 465 ARG A 927 REMARK 465 TRP A 1033 REMARK 465 LEU A 1034 REMARK 465 ALA A 1035 REMARK 465 HIS A 1036 REMARK 465 ASN A 1037 REMARK 465 VAL A 1038 REMARK 465 SER A 1039 REMARK 465 LYS A 1040 REMARK 465 ASP A 1041 REMARK 465 ASN A 1042 REMARK 465 ARG A 1043 REMARK 465 GLN A 1044 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 123 111.67 -167.64 REMARK 500 TYR A 165 -68.18 -100.42 REMARK 500 GLU A 197 -77.94 -46.73 REMARK 500 GLN A 206 66.95 -101.72 REMARK 500 HIS A 247 40.08 -97.12 REMARK 500 ASN A 253 66.91 -118.15 REMARK 500 GLU A 288 1.45 -62.34 REMARK 500 LEU A 319 97.05 -56.99 REMARK 500 ILE A 328 -74.11 -70.32 REMARK 500 ASN A 364 150.26 -44.37 REMARK 500 TRP A 371 -64.75 -105.69 REMARK 500 MET A 387 34.86 -93.52 REMARK 500 ALA A 661 -38.34 -39.81 REMARK 500 SER A 675 77.78 -153.44 REMARK 500 HIS A 730 76.56 58.25 REMARK 500 ASP A 736 118.04 -170.84 REMARK 500 GLU A 742 -93.46 -93.44 REMARK 500 THR A 750 -153.03 -136.23 REMARK 500 LYS A 757 70.40 56.25 REMARK 500 ARG A 821 28.58 49.23 REMARK 500 ALA A 854 -60.59 -23.39 REMARK 500 ASP A 911 86.12 47.39 REMARK 500 LEU A 916 48.80 39.78 REMARK 500 ARG A 929 90.33 32.45 REMARK 500 LEU A 989 88.28 -155.52 REMARK 500 SER A 990 -44.35 -144.91 REMARK 500 LYS A 999 12.04 -69.88 REMARK 500 ASP A1000 -38.18 -130.73 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A4359 DISTANCE = 6.25 ANGSTROMS REMARK 525 HOH A4360 DISTANCE = 6.96 ANGSTROMS REMARK 525 HOH A4361 DISTANCE = 7.53 ANGSTROMS REMARK 525 HOH A4362 DISTANCE = 8.11 ANGSTROMS REMARK 525 HOH A4363 DISTANCE = 8.16 ANGSTROMS REMARK 525 HOH A4364 DISTANCE = 8.21 ANGSTROMS REMARK 525 HOH A4365 DISTANCE = 8.46 ANGSTROMS REMARK 525 HOH A4366 DISTANCE = 8.79 ANGSTROMS REMARK 525 HOH A4367 DISTANCE = 9.11 ANGSTROMS REMARK 525 HOH A4368 DISTANCE = 9.14 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6PF A 4000 DBREF 5L72 A 106 1044 UNP O35904 PK3CD_MOUSE 106 1043 SEQADV 5L72 GLY A 105 UNP O35904 EXPRESSION TAG SEQADV 5L72 GLN A 508 UNP O35904 INSERTION SEQRES 1 A 940 GLY GLY ASP ARG VAL LYS LYS LEU ILE ASN SER GLN ILE SEQRES 2 A 940 SER LEU LEU ILE GLY LYS GLY LEU HIS GLU PHE ASP SER SEQRES 3 A 940 LEU ARG ASP PRO GLU VAL ASN ASP PHE ARG THR LYS MET SEQRES 4 A 940 ARG GLN PHE CYS GLU GLU ALA ALA ALA HIS ARG GLN GLN SEQRES 5 A 940 LEU GLY TRP VAL GLU TRP LEU GLN TYR SER PHE PRO LEU SEQRES 6 A 940 GLN LEU GLU PRO SER ALA ARG GLY TRP ARG ALA GLY LEU SEQRES 7 A 940 LEU ARG VAL SER ASN ARG ALA LEU LEU VAL ASN VAL LYS SEQRES 8 A 940 PHE GLU GLY SER GLU GLU SER PHE THR PHE GLN VAL SER SEQRES 9 A 940 THR LYS ASP MET PRO LEU ALA LEU MET ALA CYS ALA LEU SEQRES 10 A 940 ARG LYS LYS ALA THR VAL PHE ARG GLN PRO LEU VAL GLU SEQRES 11 A 940 GLN PRO GLU GLU TYR ALA LEU GLN VAL ASN GLY ARG HIS SEQRES 12 A 940 GLU TYR LEU TYR GLY ASN TYR PRO LEU CYS HIS PHE GLN SEQRES 13 A 940 TYR ILE CYS SER CYS LEU HIS SER GLY LEU THR PRO HIS SEQRES 14 A 940 LEU THR MET VAL HIS SER SER SER ILE LEU ALA MET ARG SEQRES 15 A 940 ASP GLU GLN SER ASN PRO ALA PRO GLN VAL GLN LYS PRO SEQRES 16 A 940 ARG ALA LYS PRO PRO PRO ILE PRO ALA LYS LYS PRO SER SEQRES 17 A 940 SER VAL SER LEU TRP SER LEU GLU GLN PRO PHE SER ILE SEQRES 18 A 940 GLU LEU ILE GLU GLY ARG LYS VAL ASN ALA ASP GLU ARG SEQRES 19 A 940 MET LYS LEU VAL VAL GLN ALA GLY LEU PHE HIS GLY ASN SEQRES 20 A 940 GLU MET LEU CYS LYS THR VAL SER SER SER GLU VAL ASN SEQRES 21 A 940 VAL CYS SER GLU PRO VAL TRP LYS GLN ARG LEU GLU PHE SEQRES 22 A 940 ASP ILE SER VAL CYS ASP LEU PRO ARG MET ALA ARG LEU SEQRES 23 A 940 CYS PHE ALA LEU TYR ALA VAL VAL GLU LYS ALA LYS LYS SEQRES 24 A 940 ALA ARG SER THR LYS LYS LYS SER LYS LYS ALA ASP CYS SEQRES 25 A 940 PRO ILE ALA TRP ALA ASN LEU MET LEU PHE ASP TYR LYS SEQRES 26 A 940 ASP GLN LEU LYS THR GLY GLU ARG CYS LEU TYR MET TRP SEQRES 27 A 940 PRO SER VAL PRO ASP GLU LYS GLY GLU LEU LEU ASN PRO SEQRES 28 A 940 ALA GLY THR VAL ARG GLY ASN PRO ASN THR GLU SER ALA SEQRES 29 A 940 ALA ALA LEU VAL ILE TYR LEU PRO GLU VAL ALA PRO HIS SEQRES 30 A 940 PRO VAL TYR PHE PRO ALA LEU GLU LYS ILE LEU GLU LEU SEQRES 31 A 940 GLY ARG HIS GLY GLU ARG GLY ARG ILE THR GLU GLU GLU SEQRES 32 A 940 GLN LEU GLN LEU ARG GLU ILE LEU GLU ARG ARG GLY SER SEQRES 33 A 940 GLY GLU LEU TYR GLU HIS GLU LYS ASP LEU VAL TRP LYS SEQRES 34 A 940 MET ARG HIS GLU VAL GLN GLU HIS PHE PRO GLU ALA LEU SEQRES 35 A 940 ALA ARG LEU LEU LEU VAL THR LYS TRP ASN LYS HIS GLU SEQRES 36 A 940 ASP VAL ALA GLN MET LEU TYR LEU LEU CYS SER TRP PRO SEQRES 37 A 940 GLU LEU PRO VAL LEU SER ALA LEU GLU LEU LEU ASP PHE SEQRES 38 A 940 SER PHE PRO ASP CYS TYR VAL GLY SER PHE ALA ILE LYS SEQRES 39 A 940 SER LEU ARG LYS LEU THR ASP ASP GLU LEU PHE GLN TYR SEQRES 40 A 940 LEU LEU GLN LEU VAL GLN VAL LEU LYS TYR GLU SER TYR SEQRES 41 A 940 LEU ASP CYS GLU LEU THR LYS PHE LEU LEU GLY ARG ALA SEQRES 42 A 940 LEU ALA ASN ARG LYS ILE GLY HIS PHE LEU PHE TRP HIS SEQRES 43 A 940 LEU ARG SER GLU MET HIS VAL PRO SER VAL ALA LEU ARG SEQRES 44 A 940 PHE GLY LEU ILE MET GLU ALA TYR CYS ARG GLY SER THR SEQRES 45 A 940 HIS HIS MET LYS VAL LEU MET LYS GLN GLY GLU ALA LEU SEQRES 46 A 940 SER LYS LEU LYS ALA LEU ASN ASP PHE VAL LYS VAL SER SEQRES 47 A 940 SER GLN LYS THR THR LYS PRO GLN THR LYS GLU MET MET SEQRES 48 A 940 HIS MET CYS MET ARG GLN GLU THR TYR MET GLU ALA LEU SEQRES 49 A 940 SER HIS LEU GLN SER PRO LEU ASP PRO SER THR LEU LEU SEQRES 50 A 940 GLU GLU VAL CYS VAL GLU GLN CYS THR PHE MET ASP SER SEQRES 51 A 940 LYS MET LYS PRO LEU TRP ILE MET TYR SER SER GLU GLU SEQRES 52 A 940 ALA GLY SER ALA GLY ASN VAL GLY ILE ILE PHE LYS ASN SEQRES 53 A 940 GLY ASP ASP LEU ARG GLN ASP MET LEU THR LEU GLN MET SEQRES 54 A 940 ILE GLN LEU MET ASP VAL LEU TRP LYS GLN GLU GLY LEU SEQRES 55 A 940 ASP LEU ARG MET THR PRO TYR GLY CYS LEU PRO THR GLY SEQRES 56 A 940 ASP ARG THR GLY LEU ILE GLU VAL VAL LEU HIS SER ASP SEQRES 57 A 940 THR ILE ALA ASN ILE GLN LEU ASN LYS SER ASN MET ALA SEQRES 58 A 940 ALA THR ALA ALA PHE ASN LYS ASP ALA LEU LEU ASN TRP SEQRES 59 A 940 LEU LYS SER LYS ASN PRO GLY GLU ALA LEU ASP ARG ALA SEQRES 60 A 940 ILE GLU GLU PHE THR LEU SER CYS ALA GLY TYR CYS VAL SEQRES 61 A 940 ALA THR TYR VAL LEU GLY ILE GLY ASP ARG HIS SER ASP SEQRES 62 A 940 ASN ILE MET ILE ARG GLU SER GLY GLN LEU PHE HIS ILE SEQRES 63 A 940 ASP PHE GLY HIS PHE LEU GLY ASN PHE LYS THR LYS PHE SEQRES 64 A 940 GLY ILE ASN ARG GLU ARG VAL PRO PHE ILE LEU THR TYR SEQRES 65 A 940 ASP PHE VAL HIS VAL ILE GLN GLN GLY LYS THR ASN ASN SEQRES 66 A 940 SER GLU LYS PHE GLU ARG PHE ARG GLY TYR CYS GLU ARG SEQRES 67 A 940 ALA TYR THR ILE LEU ARG ARG HIS GLY LEU LEU PHE LEU SEQRES 68 A 940 HIS LEU PHE ALA LEU MET ARG ALA ALA GLY LEU PRO GLU SEQRES 69 A 940 LEU SER CYS SER LYS ASP ILE GLN TYR LEU LYS ASP SER SEQRES 70 A 940 LEU ALA LEU GLY LYS THR GLU GLU GLU ALA LEU LYS HIS SEQRES 71 A 940 PHE ARG VAL LYS PHE ASN GLU ALA LEU ARG GLU SER TRP SEQRES 72 A 940 LYS THR LYS VAL ASN TRP LEU ALA HIS ASN VAL SER LYS SEQRES 73 A 940 ASP ASN ARG GLN HET 6PF A4000 32 HETNAM 6PF N-[6-(5-METHANESULFONAMIDO-6-METHOXYPYRIDIN-3-YL)-1,3- HETNAM 2 6PF DIHYDRO-2-BENZOFURAN-4-YL]-2-(MORPHOLIN-4-YL)ACETAMIDE FORMUL 2 6PF C21 H24 N4 O6 S FORMUL 3 HOH *268(H2 O) HELIX 1 AA1 VAL A 109 GLY A 122 1 14 HELIX 2 AA2 LEU A 125 LEU A 131 1 7 HELIX 3 AA3 ASP A 133 GLN A 155 1 23 HELIX 4 AA4 GLY A 158 PHE A 167 1 10 HELIX 5 AA5 MET A 212 ARG A 229 1 18 HELIX 6 AA6 GLN A 235 GLU A 237 5 3 HELIX 7 AA7 PRO A 255 HIS A 258 5 4 HELIX 8 AA8 PHE A 259 SER A 268 1 10 HELIX 9 AA9 SER A 279 GLU A 288 1 10 HELIX 10 AB1 SER A 315 LEU A 319 5 5 HELIX 11 AB2 ALA A 487 GLY A 495 1 9 HELIX 12 AB3 THR A 504 ARG A 517 1 14 HELIX 13 AB4 TYR A 524 MET A 534 1 11 HELIX 14 AB5 MET A 534 PHE A 542 1 9 HELIX 15 AB6 ALA A 545 THR A 553 1 9 HELIX 16 AB7 LYS A 557 SER A 570 1 14 HELIX 17 AB8 PRO A 575 LEU A 580 1 6 HELIX 18 AB9 GLU A 581 ASP A 584 5 4 HELIX 19 AC1 ASP A 589 ARG A 601 1 13 HELIX 20 AC2 THR A 604 VAL A 618 1 15 HELIX 21 AC3 LEU A 619 GLU A 622 5 4 HELIX 22 AC4 CYS A 627 LEU A 638 1 12 HELIX 23 AC5 ASN A 640 SER A 653 1 14 HELIX 24 AC6 VAL A 660 GLY A 674 1 15 HELIX 25 AC7 SER A 675 THR A 706 1 32 HELIX 26 AC8 THR A 707 ARG A 720 1 14 HELIX 27 AC9 GLN A 721 LEU A 728 1 8 HELIX 28 AD1 VAL A 746 CYS A 749 5 4 HELIX 29 AD2 LEU A 784 GLU A 804 1 21 HELIX 30 AD3 ILE A 834 LEU A 839 1 6 HELIX 31 AD4 ASP A 853 ASN A 863 1 11 HELIX 32 AD5 PRO A 864 GLU A 866 5 3 HELIX 33 AD6 ALA A 867 LEU A 889 1 23 HELIX 34 AD7 THR A 935 GLN A 943 1 9 HELIX 35 AD8 ASN A 949 ARG A 969 1 21 HELIX 36 AD9 HIS A 970 MET A 981 1 12 HELIX 37 AE1 ARG A 982 GLY A 985 5 4 HELIX 38 AE2 CYS A 991 LEU A 1002 1 12 HELIX 39 AE3 THR A 1007 SER A 1026 1 20 HELIX 40 AE4 SER A 1026 ASN A 1032 1 7 SHEET 1 AA1 5 PHE A 203 SER A 208 0 SHEET 2 AA1 5 ALA A 189 PHE A 196 -1 N VAL A 192 O PHE A 205 SHEET 3 AA1 5 HIS A 273 HIS A 278 1 O MET A 276 N LYS A 195 SHEET 4 AA1 5 TYR A 239 VAL A 243 -1 N GLN A 242 O THR A 275 SHEET 5 AA1 5 TYR A 249 LEU A 250 -1 O LEU A 250 N LEU A 241 SHEET 1 AA2 4 VAL A 370 SER A 380 0 SHEET 2 AA2 4 PRO A 322 GLY A 330 -1 N ILE A 325 O LEU A 375 SHEET 3 AA2 4 ALA A 470 LEU A 475 -1 O VAL A 472 N GLU A 329 SHEET 4 AA2 4 GLY A 435 TYR A 440 -1 N ARG A 437 O ILE A 473 SHEET 1 AA3 3 GLU A 352 MET A 353 0 SHEET 2 AA3 3 LYS A 340 HIS A 349 -1 N HIS A 349 O GLU A 352 SHEET 3 AA3 3 VAL A 363 ASN A 364 -1 O VAL A 363 N LEU A 341 SHEET 1 AA4 5 VAL A 358 SER A 359 0 SHEET 2 AA4 5 LYS A 340 HIS A 349 -1 N ALA A 345 O VAL A 358 SHEET 3 AA4 5 ARG A 389 VAL A 397 -1 O VAL A 397 N LYS A 340 SHEET 4 AA4 5 CYS A 416 MET A 424 -1 O LEU A 423 N LEU A 390 SHEET 5 AA4 5 TRP A 442 PRO A 443 -1 O TRP A 442 N TRP A 420 SHEET 1 AA5 2 LEU A 731 SER A 733 0 SHEET 2 AA5 2 ASP A 736 LEU A 741 -1 O LEU A 741 N LEU A 731 SHEET 1 AA6 3 GLU A 743 VAL A 744 0 SHEET 2 AA6 3 LEU A 759 SER A 765 -1 O SER A 764 N GLU A 743 SHEET 3 AA6 3 THR A 750 PHE A 751 -1 N THR A 750 O TRP A 760 SHEET 1 AA7 5 GLU A 743 VAL A 744 0 SHEET 2 AA7 5 LEU A 759 SER A 765 -1 O SER A 764 N GLU A 743 SHEET 3 AA7 5 GLY A 769 ASN A 780 -1 O ILE A 776 N ILE A 761 SHEET 4 AA7 5 THR A 822 GLU A 826 -1 O GLY A 823 N LYS A 779 SHEET 5 AA7 5 CYS A 815 GLY A 819 -1 N THR A 818 O THR A 822 SHEET 1 AA8 3 SER A 831 THR A 833 0 SHEET 2 AA8 3 ILE A 899 ARG A 902 -1 O ILE A 901 N ASP A 832 SHEET 3 AA8 3 LEU A 907 HIS A 909 -1 O PHE A 908 N MET A 900 SITE 1 AC1 12 MET A 752 SER A 754 PRO A 758 LYS A 779 SITE 2 AC1 12 LEU A 784 ASP A 787 ILE A 825 GLU A 826 SITE 3 AC1 12 VAL A 828 ASN A 836 MET A 900 ASP A 911 CRYST1 141.400 64.360 115.830 90.00 102.88 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007072 0.000000 0.001617 0.00000 SCALE2 0.000000 0.015538 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008856 0.00000